8 April 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today (Monday 8 April) published advice accepting three new medicines.

Erenumab (Aimovig) was accepted for use in patients with chronic migraine, in whom the use of at least three other preventive medicines has been unsuccessful. 

Lenvatinib (Lenvima) was accepted for the treatment of a type of liver cancer called hepatocellular carcinoma.

Read SMC press release